List of Speakers from Abroad |
|
Prof. Robert H. Grubbs, Nobel laureate, California Institute of Technology, Pasadena, USA
|
|
Prof. Vadim T. Ivanov, Shemyakin-Ovchinnikov Institute of Bioorganic chemistry, Russia
Challenges and practical perspectives of peptidomic research
|
|
Prof. Cynthia J. Burrows, Senior Editor, Journal of Organic chemistry, University of Utah, ,USA
Lessons from DNA Damage Applied to siRNA
|
|
Prof. Colin J Suckling, University of Strathclyde, Glasgow, UK
Manipulating biological processes with novel heterocyclic compounds
|
|
Prof. David St. C. Black, Secretary General, IUPAC, University of New South Wales , Sydney, Australia
The Role of Molecular Activation, in the Generation of New Indole Reactivity
|
|
Prof. Nancy B. Jackson, Sandia National Laboratories, New Mexico
The Role of Safety and Security in Chemical Sustainability
|
|
Prof. Dr. Stefan Bräse, Universität Karlsruhe (TH)/ Karlsruhe Institute of Technology, Germany
Chemical Biology with Natural Products
|
|
Dr. John C. Amedio, Seaside Therapeutics, 840 Memorial Drive, Cambridge, USA
Palifosfamide (ZYMAFOS™): A Novel Molecule for the Treatment of Soft Tissue Sarcoma
|
|
Prof. Binghe Wang, Georgia State University, Atlanta, USA
Boronolectins and fluorescent boronolectins as potential research tools and diagnostic
|
|
Dr. Janos Fischer, Richter Plc., Budapest, Hungary
Analogue-based Drug Discovery: Lead and Drug Optimization
|
|
Prof. Jyoti Chattopadhyaya, Uppsala University, Sweden
The Importance of Being Nucleic Acids – Some Structural and Reactivity Considerations
|
|
Prof. Dr. Andrea Vasella, Laboratory of Organic Chemistry, ETH Zurich, Zurich, Switzerland
A New Type of Oligonucleotide Analogues
|
|
Prof. Tsann-Long Su, Institute of Biomedical Sciences, Academia Sinica, Taiwan
Oncologic Drug Development: From Target Identification to Bedside
|
|
Dr. David Haydon, Prolysis Ltd. UK
Discovery and Development of Novel Antibacterials: Antibacterial inhibitors of the essential cell division protein FtsZ
|
|
Prof. Michael D. Threadgill, University of Bath. UK
NAD-requiring enzymes as targets for medicinal chemistry
|
|
Prof. Dr. Cemil Ogretir, Osmangazi University, Turkey
Theoretical Approaches to Drug Design Case Studies On QSAR and QSPR
|
|
Dr. Graham B. Jones, Northeastern University, 102 Hurtig Hall, USA
Natural Product Inspired Probes of DNA and RNA Microenvironments
|
|
Prof. Dr. Jörg Senn- RDP, Nycomed GmbH, Germany
Analogue - based Design of Gastric Acid Anti-secretory Agents: Past and Present
|
|
Prof. Siriwardena Aloysius, Universite de-Picardie, France
Synthetic tools that modulate the action glycan metabolising enzymes: the simpler the better ?
|
|
Prof. Abu Salim Mustafa, Kuwait University, Safat, Kuwait
Cell mediated immunity assays identify ESAT6-family of proteins for diagnostic and vaccine relevance using overlapping synthetic peptides corresponding to genomic regions of difference of Mycobacterium tuberculosis
|
|
Dr. Leena Otsomaa, ORION PHARMA, Orionintie, Finland
Challenges of Medicinal Chemists
|
|
Dr. John Primeau, AstraZeneca, Boston, USA
|
Dr. Michael N. Liebman, Strategic Medicine, Inc. PA 19348,USA
|
Dr. Soumitra Banerjee, Fine Solutions Ltd, Israel
|
Prof. Mahesh K. Lakshman, The City University of New York, New York, USA
|
Dr. Barbara Zajc, The City University of New York, USA
|
Dr. Sham Nikam, Nycomed, Germany
|
Dr. Ashvani Kumar Singh, Vertex Pharmaceuticals San Diego, USA
|
Dr. Mukund S. Chorghade, THINQ Pharma, USA
|
Dr. A. Ganesan, Southampton, UK
|
|
List of Speakers from India
|
|
Prof. S. Chandrasekaran, Indian Institute of Sciences, Banglore
Studies on Lysine / Tyrosine based Peptide Conjugates as inhibitors of Sir2 activity
|
|
Prof. Asit K. Chakraborti, National Institute of Pharmaceutical Education and Research Punjab
Sustainable Development: An Exploration to the Wonderland of Ionic Liquids
|
|
Dr. Tushar Kanti Chakraborty, Central Drug Research Institute
Prof. Anil K. Singh, Indian Institute of Technology, Bombay,Mumbai
Design, synthesis and antiradical activity of novel Vitamin E compounds
|
|
Dr. Ram Vishwakarma, Indian Institute of Integrative Medicine, Jammu
|
|
Dr Sreeni Devidas, GVK Biochem, Hyderabad
Drug Discovery: Is reliance increasing on India and are we prepared for the challenges?
|
|
Prof. V. K Tandon, Lucknow University
Proliferation and apoptosis in cancer cells: the role of chromophore
|
|
Dr. Vinod Bhakuni, Central Drug Research Institute
An enzymatically active fibrillar film of bacteriophage-associated hyaluronate lyase (hylp2)
|
|
Dr. Sanjay Kumar, Piramal Life Sciences, Mumbai
Discovery of novel inhibitors targeting HIF-1alpha towards anticancer drug development
|
|
Dr. Ram Rajasekharan, Central Institute of Medicinal and Aromatic Plants, Lucknow
Meroterpenoid is a new biopesticide; a simple method of biopesticide (SPINOSID) production from fungi
|
|
Dr. Parthasarathi Das, Dr. Reddy’s Laboratories Ltd., Hyderabad
Macrolide and Ketolide Antibiotics: Synthetic Studies on Narbonolid
|
|
Dr. Surat Kumar, Dayalbagh Educational Institute, Agra
Nucleic Acid Binding of Alkaloids: Fluorescence, Docking and Molecular Modeling Approaches
|
|
Dr. Shiv Kumar Agarwal, Unimark Remedies Ltd, PUNE
Anticancer Drugs derived from Natural Products
|
|
Dr. Rajiv Sharma, Piramal Life Sciences Limited, Mumbai
Structure-CYP Inhibition Relationships
|
|
Dr. Mohan Prasad, Ranbaxy, Gurgaon, Haryana
Process development ad scale-up from Generic perspective
|
|
Dr. Dalip Kumar, Birla Institute of Technology, Pilani
Design and Synthesis of Novel Bioactive Heterocycles as Potential Anticancer Agents
|
|
Prof. K S Rangappa, Mysore University, Mysore
Implications of heterocycles as chemotherapeutic agents: drug discovery programe
|
|
Dr. Abhijit Roychoudhury, Piramal Life Science Limited, Mumbai
Small molecule mTOR inhibitors as anti-cancer agents: Is selectivity an issue?
|
|
Dr. Diwan Singh, Dehli University Dehli
Tetraoxanea as Artemisinin Mimics: Synthesis and Antimalarial Activity Evaluations
|
|
Dr. Bipin Pandey, Zydus-Cadila, Ahmadabad
Importance of Salts and Polymorphs during Drug Discovery and Development
Dr.Ian A Cliffe , ,Ranbaxy Laboratories Limited, Gurgaon
Use of Virtual Compound Libraries for Chemical Hit Finding
|
|
Dr. Nilesh M. Dagia, Piramal Life Science Limited, Mumbai
The α But Not γ or δ, Isoform of PI3K is The Predominant Contributor in the Production of Pro-Inflammatory Cytokines"
|
|
Prof. M. S. Singare, BAMU, Aurangabad
Quinoline based various antimicrobials
|
|
Dr. Arun K. Sinha, Institute of Himalayan, Bioresource Technology (CSIR), Palampur
Exploring environmentally benign chemical and biocatalytic routes for bioactive phenolics
|
|
Dr. Anil Kumar, Birla Institute of Technology, Pilani
Design and Synthesis of Src Tyrosine Kinase Inhibitors as Therapeutic Agents
|
|
Prof. Ashok Prasad, Dehli University Delhi
Nucleosides and Nucleic Acids: Present and Future Drugs
|
|
Prof. V S Parmar, Department of Chemistry, Delhi University Delhi
|
|
Prof. V. K. Singh, Indian Institute of Science Education and Research, Bhopal
|
|
Prof. Anamik Shah, Department of Chemistry, Saurastra University, Rajkot
|
|
Dr. R. A. Mane, BAMU Aurangabad
Dr.Veena Agarwal, Senior Vice President, Piramal Life Sciences Ltd., Goregaon (East)Mumbai |
|
